NYSE:TEVA
Teva Pharmaceutical Industries Limited Stock News
$16.81
+0.520 (+3.19%)
At Close: May 20, 2024
TEVA Misses on Q3 Earnings, Cuts 2022 Sales View, Stock Down
12:03pm, Friday, 04'th Nov 2022
TEVA reports dismal Q3 results, missing estimates for both earnings and sales. It slightly lowers its sales expectations for 2022 while keeping the adjusted earnings per share guidance intact.
Why Teva Stock Sank On Thursday
09:57pm, Thursday, 03'rd Nov 2022 The Motley Fool
There were two major developments with the company, both of which involved piles of money.
Why Teva Stock Sank On Thursday
05:57pm, Thursday, 03'rd Nov 2022
There were two major developments with the company, both of which involved piles of money.
Teva Pharmaceutical Industries (TEVA) Q3 2022 Earnings Call Transcript
04:30pm, Thursday, 03'rd Nov 2022 The Motley Fool
TEVA earnings call for the period ending September 30, 2022.
Teva Pharmaceutical Industries Limited (TEVA) Q3 2022Earnings Call Transcript
11:46am, Thursday, 03'rd Nov 2022
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Q3 2022 Earnings Conference Call November 3, 2022 8:00 AM ET Company Participants Ran Meir - Senior Vice President, Head of Investor Relations Kare
Teva Pharmaceuticals Will Pay Up To $523 Million In New York For Opioid Settlement
11:05am, Thursday, 03'rd Nov 2022
The Israeli company will shell out as much as $4.2 billion nationwide as part of a tentative deal.
New York Attorney General Letitia James secures $523 million from Teva Pharmaceuticals for role in opioid crisis
09:38am, Thursday, 03'rd Nov 2022
The New York Attorney General's office announced it has secured $523 million from Teva Pharmaceuticals and affiliates for its role in the opioid crisis, effectively marking the end of the state's liti
FDA warns of Adderall shortage after Teva manufacturing delay
05:13pm, Friday, 14'th Oct 2022
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss the FDA's warning of an Adderall shortage after Teva experiences a manufacturing delay.
What To Do After EU Hits Teva With Antitrust Concerns
09:51pm, Monday, 10'th Oct 2022
The European Commission's antitrust accusation against Teva is poorly timed. Teva's selling momentum could continue from here.
Why Teva Stock Shot More Than 3% Higher Today
09:55pm, Friday, 30'th Sep 2022 The Motley Fool
The generic drugs specialist settled one of a number of state lawsuits over its business practices.
Why Teva Stock Shot More Than 3% Higher Today
05:55pm, Friday, 30'th Sep 2022
The generic drugs specialist settled one of a number of state lawsuits over its business practices.
Teva Pharmaceutical: Slow And Steady Road To A Higher Share Price
05:02pm, Wednesday, 28'th Sep 2022
Teva is a solid company which faces/faced headwinds from their high debt load and opioid crisis settlement uncertainty. But with most of the settlement uncertainty behind them and their efforts to sig
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
04:57am, Sunday, 18'th Sep 2022
Teva Pharmaceutical Industries expects to finalise an opioid settlement in the United States by year-end and start paying in 2023, its chief executive said on Sunday.
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike
04:21am, Sunday, 18'th Sep 2022
The Zantac lawsuit will have minimal impact on Teva Pharmaceutical's financial position. At the end of August 2022, the company received approval in Europe for Ranivisio, which is a biosimilar of Luce
Adderall is running low nationwide amid soaring demand -- here's how ADHD patients are coping
09:48pm, Friday, 16'th Sep 2022 MarketWatch
Patients with attention-deficit hyperactivity disorder are having trouble filling prescriptions of Adderall and generic versions of the drug amid growing demand and a shortage of the medication, acc
